Immunic, Inc. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $121 M for Immunic, Inc., 4.2 times as much (market caps of Oct 28, 2026 for Immunic, Inc. and Oct 6, 2026 for Regenxbio Inc.).
- Both made a net loss: $97 M for Immunic, Inc. and $194 M for Regenxbio Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Immunic, Inc. IMUX · #18,073 in the world | Regenxbio Inc. RGNX · #12,428 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $121 M | $513 M |
| Revenue | — | $170 M |
| Net income | $-97 M▲ best | $-194 M |
| Employees | — | 372 |
| Valuation | ||
| Price to sales | — | 3.3× |
| Price to book | — | 5.0× |
| Free cash flow yield | -71.1% | -24.6%▲ best |
| Profitability | ||
| Operating margin | — | -94.6% |
| Net margin | — | -113.8% |
| Return on equity | — | -107.0% |
| Growth | ||
| Revenue growth | — | 104.5% |
| Revenue growth, 3 years a year | — | 14.8% |
| Cash | ||
| Free cash flow margin | — | -74.1% |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Immunic, Inc. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $121 M for Immunic, Inc., 4.2 times as much (market caps of Oct 28, 2026 for Immunic, Inc. and Oct 6, 2026 for Regenxbio Inc.).
Which makes more money, Immunic, Inc. or Regenxbio Inc.?
Both made a net loss: $97 M for Immunic, Inc. and $194 M for Regenxbio Inc.
More about Immunic, Inc.
More about Regenxbio Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.